Understanding the drivers and consequences of early-onset type 2 diabetes
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although there is some individual responsibility for maintaining a healthy weight, 133 this approach oversimplifies the interplay of genes, biology, and environmental factors influencing weight gain (reviewed in the first two papers in this Series 11,12 ).134”
From Managing early-onset type 2 diabetes in the individual and at the population level (2025) · cites this paper as [12]
In the citing paper
“the lifetime risk of atherosclerotic cardiovascular disease in individuals with early-onset type 2 diabetes is markedly elevated”
From Managing early-onset type 2 diabetes in the individual and at the population level (2025) · cites this paper as [12]
In the citing paper
“People with EOT2D have an aggressive disease trajectory, rapid pancreatic beta-cell dysfunction, and postprandial glycemic excursions [4].”
From Digital Management of Early-Onset Type 2 Diabetes: Empowerment, Challenges, and Future Outlook (2026) · cites this paper as [4]
In the citing paper
“Early-onset type 2 diabetes (EOT2D), defined as a diabetes diagnosis before 40 years of age, is rising globally and associated with an aggressive disease course and early complications.”
From Digital Management of Early-Onset Type 2 Diabetes: Empowerment, Challenges, and Future Outlook (2026) · cites this paper as [4]
In the citing paper
“In addition, among people with EOT2D who face a longer lifetime exposure to hyperglycemia and are at risk of cardiovascular-kidney complications and premature death than those with usual‑onset T2D, such anticipatory tools are particularly relevant because they enable earlier, more precise risk detection and support proactive treatment optimization over decades of disease course [4, 50, 51].”
From Digital Management of Early-Onset Type 2 Diabetes: Empowerment, Challenges, and Future Outlook (2026) · cites this paper as [4]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Definition and diagnostic criteria of clinical obesity
Rubino, F., Cummings, D. E., Eckel, R. H., Cohen, R. V., Wilding, J. P. H., Brown, W. A., Stanford, F. C., Batterham, R. L., Farooqi, I. S., Farpour-Lambert, N. J., et al. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00316-4 · Cited by 1,811
Genetics of diabetes mellitus and diabetes complications
Cole, J. B., & Florez, J. C. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0278-5 · Cited by 1,797
Changes in diabetes-related complications in the United States, 1990-2010
Gregg, E. W., Li, Y., Wang, J., Rios Burrows, N., Ali, M. K., Rolka, D., Williams, D. E., & Geiss, L. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1310799 · Cited by 1,749
Ismail-Beigi, F., Craven, T., Banerji, M. A., Basile, J., Calles, J., Cohen, R. M., Cuddihy, R., Cushman, W. C., Genuth, S., Grimm, R. H., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60576-4 · Cited by 1,428
The obesity transition: stages of the global epidemic
Jaacks, L. M., Vandevijvere, S., Pan, A., McGowan, C. J., Wallace, C., Imamura, F., Mozaffarian, D., Swinburn, B., & Ezzati, M. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30026-9 · Cited by 1,193
Stratton, I. M., Kohner, E. M., Aldington, S. J., Turner, R. C., Holman, R. R., Manley, S. E., & Matthews, D. R. (2001) · Diabetologia · doi:10.1007/s001250051594 · Cited by 1,019
The Lancet Commission on diabetes: using data to transform diabetes care and patient lives
Chan, J. C. N., Lim, L.-L., Wareham, N. J., Shaw, J. E., Orchard, T. J., Zhang, P., Lau, E. S. H., Eliasson, B., Kong, A. P. S., Ezzati, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32374-6 · Cited by 793
Self-citationMetabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review
Chan, W.-K., Chuah, K.-H., Rajaram, R. B., Lim, L.-L., Ratnasingam, J., & Vethakkan, S. R. (2023) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes23052 · Cited by 776
Self-citationSattar, N., Rawshani, A., Franzén, S., Rawshani, A., Svensson, A.-M., Rosengren, A., McGuire, D. K., Eliasson, B., & Gudbjörnsdottir, S. (2019) · Circulation · doi:10.1161/circulationaha.118.037885 · Cited by 555
Research works printed but not linked: 79
- Misra, 2023, Current insights and emerging trends in early-onset type 2 diabetes, Lancet Diabetes Endocrinol, 11, 768, 10.1016/S2213-8587(23)00225-5 · DOI · Paper page
- 2019, Effects of treatment of impaired glucose tolerance or recently diagnosed type 2 diabetes with metformin alone or in combination with insulin glargine on β-cell function: comparison of responses in youth and adults, Diabetes, 68, 1670
- Dabelea, 2017, Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood, JAMA, 317, 825, 10.1001/jama.2017.0686 · DOI · Paper page
- Nanayakkara, 2021, Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses, Diabetologia, 64, 275, 10.1007/s00125-020-05319-w · DOI · Paper page
- Ke, 2019, Excess burden of mental illness and hospitalization in young-onset type 2 diabetes: a population-based cohort study, Ann Intern Med, 170, 145, 10.7326/M18-1900 · DOI · Paper page
- Kaptoge, 2023, Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation, Lancet Diabetes Endocrinol, 11, 731, 10.1016/S2213-8587(23)00223-1 · DOI · Paper page
- Luk, 2025, Early-onset type 2 diabetes: the next major diabetes transition, Lancet, 10.1016/S0140-6736(25)00830-X · DOI · Paper page
- Xie, 2022, Global burden of type 2 diabetes in adolescents and young adults, 1990–2019: systematic analysis of the Global Burden of Disease Study 2019, BMJ, 379
- Srinivasan, 2021, The first genome-wide association study for type 2 diabetes in youth: the Progress in Diabetes Genetics in Youth (ProDiGY) Consortium, Diabetes, 70, 996, 10.2337/db20-0443 · DOI · Paper page
- Siddiqui, 2022, Young-onset diabetes in Asian Indians is associated with lower measured and genetically determined beta cell function, Diabetologia, 65, 973, 10.1007/s00125-022-05671-z · DOI · Paper page
- Chan, 2024, Multifaceted nature of young-onset diabetes—can genomic medicine improve the precision of diagnosis and management?, Journal of Translational Genetics and Genomics, 8, 13, 10.20517/jtgg.2023.36 · DOI
- Clement, 2025, Pregnancy outcomes in type 2 diabetes: a systematic review and meta-analysis, Am J Obstet Gynecol, 232, 354, 10.1016/j.ajog.2024.11.026 · DOI
- Song, 2009, Early onset type 2 diabetes mellitus: a harbinger for complications in later years—clinical observation from a secondary care cohort, QJM, 102, 799, 10.1093/qjmed/hcp121 · DOI · Paper page
- Gregg, 2019, Resurgence in diabetes-related complications, JAMA, 321, 1867, 10.1001/jama.2019.3471 · DOI · Paper page
- Wu, 2020, Secular trends in all-cause and cause-specific mortality rates in people with diabetes in Hong Kong, 2001–2016: a retrospective cohort study, Diabetologia, 63, 757, 10.1007/s00125-019-05074-7 · DOI
- Wu, 2020, Trends in diabetes-related complications in Hong Kong, 2001–2016: a retrospective cohort study, Cardiovasc Diabetol, 19, 60, 10.1186/s12933-020-01039-y · DOI
- Mottl, 2024, Major adverse events in youth-onset type 1 and type 2 diabetes: the SEARCH and TODAY studies, Diabetes Res Clin Pract, 210, 10.1016/j.diabres.2024.111606 · DOI
- Amutha, 2017, Incidence of complications in young-onset diabetes: comparing type 2 with type 1 (the young diab study), Diabetes Res Clin Pract, 123, 1, 10.1016/j.diabres.2016.11.006 · DOI
- Luk, 2014, Prospective study on the incidences of cardiovascular-renal complications in Chinese patients with young-onset type 1 and type 2 diabetes, Diabetes Care, 37, 149, 10.2337/dc13-1336 · DOI · Paper page
- Pavkov, 2006, Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians, JAMA, 296, 421, 10.1001/jama.296.4.421 · DOI · Paper page
- Hillier, 2003, Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth, Diabetes Care, 26, 2999, 10.2337/diacare.26.11.2999 · DOI · Paper page
- Morton, 2020, The association between age of onset of type 2 diabetes and the long-term risk of end-stage kidney disease: a national registry study, Diabetes Care, 43, 1788, 10.2337/dc20-0352 · DOI
- Wu, 2021, Young age at diabetes diagnosis amplifies the effect of diabetes duration on risk of chronic kidney disease: a prospective cohort study, Diabetologia, 64, 1990, 10.1007/s00125-021-05494-4 · DOI
- Ke, 2024, Association between age at diagnosis of type 2 diabetes and hospitalization for heart failure: a population-based study, J Am Heart Assoc, 13, 10.1161/JAHA.123.030683 · DOI
- Sajjadi, 2024, Evaluating the incidence of complications among people with diabetes according to age of onset: findings from the UK Biobank, Diabet Med, 41, 10.1111/dme.15349 · DOI
- Lin, 2024, Younger-onset compared with later-onset type 2 diabetes: an analysis of the UK Prospective Diabetes Study (UKPDS) with up to 30 years of follow-up (UKPDS 92), Lancet Diabetes Endocrinol, 12, 904, 10.1016/S2213-8587(24)00242-0 · DOI · Paper page
- Chan, 2024, Young-onset diabetes in east Asians: from epidemiology to precision medicine, Endocrinol Metab (Seoul), 39, 239, 10.3803/EnM.2024.1968 · DOI
- Adler, 2003, Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64), Kidney Int, 63, 225, 10.1046/j.1523-1755.2003.00712.x · DOI · Paper page
- Krakoff, 2003, Incidence of retinopathy and nephropathy in youth-onset compared with adult-onset type 2 diabetes, Diabetes Care, 26, 76, 10.2337/diacare.26.1.76 · DOI · Paper page
- 2013, Lipid and inflammatory cardiovascular risk worsens over 3 years in youth with type 2 diabetes: the TODAY clinical trial, Diabetes Care, 36, 1758, 10.2337/dc12-2388 · DOI · Paper page
- Huo, 2018, Impact of age at diagnosis and duration of type 2 diabetes on mortality in Australia 1997–2011, Diabetologia, 61, 1055, 10.1007/s00125-018-4544-z · DOI · Paper page
- Baade, 2015, Estimating the change in life expectancy after a diagnosis of cancer among the Australian population, BMJ Open, 5, 10.1136/bmjopen-2014-006740 · doi:10.1136/bmjopen-2014-006740
- Steinarsson, 2018, Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register, Diabetologia, 61, 599, 10.1007/s00125-017-4532-8 · DOI · Paper page
- Misra, 2023, Characteristics and care of young people with type 2 diabetes included in the national diabetes audit datasets for England, Diabet Med, 40, 10.1111/dme.14940 · DOI · Paper page
- Ke, 2020, Age at diagnosis, glycemic trajectories, and responses to oral glucose-lowering drugs in type 2 diabetes in Hong Kong: a population-based observational study, PLoS Med, 17, 10.1371/journal.pmed.1003316 · DOI · Paper page
- Holman, 2008, 10-year follow-up of intensive glucose control in type 2 diabetes, N Engl J Med, 359, 1577, 10.1056/NEJMoa0806470 · DOI · Paper page
- 2008, Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes, N Engl J Med, 358, 2560, 10.1056/NEJMoa0802987 · DOI · Paper page
- Giorgino, 2016, Glucose control and vascular outcomes in type 2 diabetes: is the picture clear?, Diabetes Care, 39, S187, 10.2337/dcS15-3023 · DOI · Paper page
- Xu, 2024, Diabetes in China part 1: epidemiology and risk factors, Lancet Public Health, 9, e1089, 10.1016/S2468-2667(24)00250-0 · DOI · Paper page
- Martin, 2021, Estimating the effect of liver and pancreas volume and fat content on risk of diabetes: a Mendelian randomization study, Diabetes Care, 45, 460, 10.2337/dc21-1262 · DOI
- Tulloch, 2023, How the EAT-Lancet Commission on food in the Anthropocene influenced discourse and research on food systems: a systematic review covering the first 2 years post-publication, Lancet Glob Health, 11, e1125, 10.1016/S2214-109X(23)00212-7 · DOI
- Yuan, 2024, Determinants of childhood obesity in China, Lancet Public Health, 9, e1105, 10.1016/S2468-2667(24)00246-9 · DOI
- Sattar, 2024, Increased prevalence of younger onset type 2 diabetes: why and what could be done?, Lancet Diabetes Endocrinol, 12, 687, 10.1016/S2213-8587(24)00231-6 · DOI
- Reji, 2025, Cohort prevalence of young-onset type 2 diabetes in south Asia: a systematic review, Diabetes Res Clin Pract, 221, 10.1016/j.diabres.2025.112013 · DOI
- Ke, 2021, Migration and diabetes incidence among Chinese adults in Canada, China, Hong Kong, and Taiwan: an international population-based comparative study from 2000 to 2017, Diabetes Res Clin Pract, 180, 10.1016/j.diabres.2021.109062 · DOI
- Karin, 2022, Body mass index in adolescence, risk of type 2 diabetes and associated complications: a nationwide cohort study of men, EClinicalMedicine, 46
- Bacha, 2024, Pathophysiology and treatment of prediabetes and type 2 diabetes in youth, Diabetes Care, 47, 2038, 10.2337/dci24-0029 · DOI · Paper page
- Marcus, 2022, Longitudinal association of depressive symptoms, binge eating, and quality of life with cardiovascular risk factors in young adults with youth-onset type 2 diabetes: the TODAY2 Study, Diabetes Care, 45, 1073, 10.2337/dc21-1995 · DOI
- Lim, 2020, Association of technologically assisted integrated care with clinical outcomes in type 2 diabetes in Hong Kong using the prospective JADE Program: a retrospective cohort analysis, PLoS Med, 17, 10.1371/journal.pmed.1003367 · DOI · Paper page
- Lim, 2018, Aspects of multicomponent integrated care promote sustained improvement in surrogate clinical outcomes: a systematic review and meta-analysis, Diabetes Care, 41, 1312, 10.2337/dc17-2010 · DOI · Paper page
- Weinstock, 2020, Health care coverage and glycemic control in young adults with youth-onset type 2 diabetes: results from the TODAY2 Study, Diabetes Care, 43, 2469, 10.2337/dc20-0760 · DOI · Paper page
- Kwak, 2024, Genetic architecture and biology of youth-onset type 2 diabetes, Nat Metab, 6, 226, 10.1038/s42255-023-00970-0 · DOI
- Lyssenko, 2023, Genetics of diabetes-associated microvascular complications, Diabetologia, 66, 1601, 10.1007/s00125-023-05964-x · DOI
- Lee, 2001, Follow-up of the WHO Multinational Study of Vascular Disease in Diabetes: general description and morbidity, Diabetologia, 44, S3, 10.1007/PL00002936 · DOI
- Lee, 2001, Vascular disease in younger-onset diabetes: comparison of European, Asian and American Indian cohorts of the WHO Multinational Study of Vascular Disease in Diabetes, Diabetologia, 44, S78, 10.1007/PL00002943 · DOI
- Raets, 2023, Management of type 2 diabetes in pregnancy: a narrative review, Front Endocrinol (Lausanne), 14, 10.3389/fendo.2023.1193271 · DOI
- Murray Horwitz, 2021, Use of contraception before and after a diabetes diagnosis: an observational matched cohort study, Prim Care Diabetes, 15, 719, 10.1016/j.pcd.2021.02.012 · DOI
- 2021, Pregnancy outcomes in young women with youth-onset type 2 diabetes followed in the TODAY Study, Diabetes Care, 45, 1038
- Clement, 2025, Pregnancy outcomes in type 2 diabetes: a systematic review and meta-analysis, Am J Obstet Gynecol, 232, 354, 10.1016/j.ajog.2024.11.026 · DOI
- Bardugo, 2021, Adolescent nonalcoholic fatty liver disease and type 2 diabetes in young adulthood, J Clin Endocrinol Metab, 106, e34, 10.1210/clinem/dgaa753 · DOI
- Putri, 2024, Steatotic liver disease in pediatric obesity and increased risk for youth-onset type 2 diabetes, Diabetes Care, 47, 2196, 10.2337/dc24-1236 · DOI
- Kim, 2024, Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study, BMJ, 384
- Newton, 2016, Prevalence of prediabetes and type 2 diabetes in children with nonalcoholic fatty liver disease, JAMA Pediatr, 170, 10.1001/jamapediatrics.2016.1971 · DOI · Paper page
- Zhang, 2023, Duration of type 2 diabetes and liver-related events in nonalcoholic fatty liver disease: a landmark analysis, Hepatology, 78, 1816, 10.1097/HEP.0000000000000432 · DOI
- Zhang, 2024, A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease, Hepatol Int, 18, 1178, 10.1007/s12072-024-10702-5 · DOI
- Li, 2024, Association between age at diabetes diagnosis and subsequent incidence of cancer: a longitudinal population-based cohort, Diabetes Care, 47, 353, 10.2337/dc23-0386 · DOI
- Zhang, 2023, Incident early- and later-onset type 2 diabetes and risk of early- and later-onset cancer: prospective cohort study, Diabetes Care, 46, 120, 10.2337/dc22-1575 · DOI
- Barker, 2023, Age at type 2 diabetes diagnosis and cause-specific mortality: observational study of primary care patients in England, Diabetes Care, 46, 1965, 10.2337/dc23-0834 · DOI
- Gregg, 2024, The burden of diabetes-associated multiple long-term conditions on years of life spent and lost, Nat Med, 30, 2830, 10.1038/s41591-024-03123-2 · DOI
- Hu, 2021, Incident type 2 diabetes duration and cancer risk: a prospective study in two US cohorts, J Natl Cancer Inst, 113, 381, 10.1093/jnci/djaa141 · DOI · Paper page
- Murphy, 2022, Associations between glycemic traits and colorectal cancer: a Mendelian randomization analysis, J Natl Cancer Inst, 114, 740, 10.1093/jnci/djac011 · DOI
- Browne, 2013, The needs, concerns, and characteristics of younger Australian adults with type 2 diabetes, Diabet Med, 30, 620, 10.1111/dme.12078 · DOI · Paper page
- Liu, 2022, Early-onset type 2 diabetes and mood, anxiety, and stress-related disorders: a genetically informative register-based cohort study, Diabetes Care, 45, 2950, 10.2337/dc22-1053 · DOI
- Amare, 2017, The genetic overlap between mood disorders and cardiometabolic diseases: a systematic review of genome wide and candidate gene studies, Transl Psychiatry, 7, 10.1038/tp.2016.261 · DOI · Paper page
- Haljas, 2018, Bivariate genome-wide association study of depressive symptoms with type 2 diabetes and quantitative glycemic traits, Psychosom Med, 80, 242, 10.1097/PSY.0000000000000555 · DOI
- Pisanu, 2019, Evidence that genes involved in hedgehog signaling are associated with both bipolar disorder and high BMI, Transl Psychiatry, 9, 315, 10.1038/s41398-019-0652-x · DOI
- Khunti, 2023, Diabetes and multiple long-term conditions: a review of our current global health challenge, Diabetes Care, 46, 2092, 10.2337/dci23-0035 · DOI
- Gregg, 2025, Multiple long-term conditions as the next transition in the global diabetes epidemic, Commun Med (Lond), 5, 42, 10.1038/s43856-025-00742-9 · DOI
- Maltese, 2025, Early-onset type 2 diabetes and frailty, Lancet Diabetes Endocrinol, 13, 370, 10.1016/S2213-8587(25)00086-5 · DOI
Cited by
Managing early-onset type 2 diabetes in the individual and at the population level
Misra, S., Khunti, K., Goyal, A., Gable, D., Armocida, B., Tandon, N., Sachdev, P., Wild, S. H., Hivert, M.-F., & Beran, D. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01067-0 · Cited by 47
Self-citationDigital Management of Early-Onset Type 2 Diabetes: Empowerment, Challenges, and Future Outlook
Guo, L.-J., Low, K.-S., Tae, S.-K., & Lim, L.-L. (2026) · Current Diabetes Reports · doi:10.1007/s11892-026-01633-6
Self-citation
Metadata
- Authors
- Lim, L.-L., Jones, S., Cikomola, J. C., Hivert, M.-F., & Misra, S.
- ORCID
- Lim, Lee-Ling
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2025-06
- Volume
- 405
- Issue
- 10497
- Pages
- 2327-2340
- ISSN
- 0140-6736
- Cited by
- 59
- References
- 24
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Funders
- Universiti Malaya (IF024-2025)
- National Institute for Health and Care Research
- Wellcome Trust (223024/Z/21/Z)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Understanding the drivers and consequences of early-onset type 2 diabetes. https://app.cochat.ai/papers/10.1016/s0140-6736(25)01012-8
- The paper
- Lim, L.-L., Jones, S., Cikomola, J. C., Hivert, M.-F., & Misra, S. (2025). Understanding the drivers and consequences of early-onset type 2 diabetes. The Lancet. https://doi.org/10.1016/s0140-6736(25)01012-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.